AMPH FY 2025 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$894M

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$720M-1.7% YoY

Gross Profit

$356M49.5% margin

Operating Income

$140M19.5% margin

Net Income

$98M13.6% margin

EPS (Diluted)

$2.03

Cash Flow

Operating Cash Flow

$156M

Free Cash Flow

$121M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$840M

Stockholders' Equity

$789M

Cash & Equivalents

$170M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$720M	$732M	-1.7%
Gross Profit	$356M	$374M	-4.8%
Operating Income	$140M	$205M	-31.7%
Net Income	$98M	$160M	-38.5%